TITLE

Metabolic and reproductive consequences of the serotonin transporter promoter polymorphism (5-HTTLPR) in adult female rhesus monkeys (Macaca mulatta)

AUTHOR(S)
J. Hoffman; J. Kaplan; B. Kinkead; S. Berga; M. Wilson
PUB. DATE
April 2007
SOURCE
Endocrine (1355008X);Apr2007, Vol. 31 Issue 2, p202
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The serotonin (5HT) reuptake transporter (SERT) plays a key role in 5HT homeostasis by recycling 5HT into the presynaptic neurons. Recently, polymorphisms in the length of the promoter region of the gene that encodes SERT have been linked to functional differences in reactivity to psychosocial stress, as the short (s) promoter length allele shows reduced transcriptionally activity in vitro and is associated with reduced 5HT activity and increased vulnerability to affective disorders. Given 5HT’s important role in appetite regulation, polymorphisms in the SERT gene could also affect metabolic parameters. In addition, since reduced 5HT activity may also predispose females to reproductive deficits, polymorphisms in the SERT gene may help explain individual differences in ovulatory function. The present study, using a rhesus monkey model, tested the hypothesis that the presence of the s-variant allele would be associated with altered metabolic regulation and impaired ovulatory cycles compared with the l/l genotype. Females homozygous for the long allele in the SERT gene (l/l, n = 19) were compared to those with the s-variant allele (l/s or s/s, n = 20). All females had similar social histories. Body weights (P = 0.026) but not heights (P = 0.618) were significantly lower in s-variant compared to l/l females. In addition, both BMI (P = 0.032) and sagittal abdominal diameters (SAD) (P = 0.031), as indices of adiposity, were significantly lower in s-variant females. Consistent with these differences, fasting and non-fasting levels of leptin were significantly lower in s-variant females (P = 0.002). While there were no genotype differences in non-fasting levels of insulin, s-variant females had significantly lower concentrations of insulin during a fast than did l/l females (P = 0.052). Neither glucose, T 3, T 4, nor ghrelin varied significantly between groups during either the fasted or non-fasted condition (P > 0.05). Analysis of a subset of females indicated that significantly fewer s-variant females (62.5%) exhibited ovulatory cycles than l/l females (100%, P < 0.05). However, there were no differences in serum estradiol or progesterone in l/l females and those s-variant females that did ovulate (P > 0.05). In addition, females with the s-variant genotype also had reduced 5HT activity (P = 0.030), assessed from the acute increase in serum prolactin following the administration of the 5HT reuptake inhibitor, citalopram. Finally, s-variant females were significantly less responsive to glucocorticoid negative feedback (P = 0.030) yet more responsive to corticotropin releasing hormone (CRH, P = 0.016) in terms of plasma cortisol than were l/l females. These data indicate that adult female rhesus monkeys with the s-variant polymorphism in the SERT gene exhibit metabolic and reproductive alterations in conjunction with reduced serotonergic responsivity and increased LHPA activity and suggest the possibility that this genotype may predispose females exposed to psychosocial stressors to further metabolic and reproductive deficits.
ACCESSION #
26647600

 

Related Articles

  • Serotonin Transporters. Inoue, Takeshi; Kusumi, Ichiro; Yoshioka, Mitsuhiro // Current Drug Targets - CNS & Neurological Disorders;Oct2002, Vol. 1 Issue 5, p519 

    The serotonin transporter is most well known as the site of action of the serotonin reuptake inhibitors, which were initially developed as antidepressants, but now are the most widely used agents in the treatment of many additional neuropsychiatric and related disorders. The discovery that the...

  • Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Anderson, George M.; Barr, Christina S.; Lindell, Stephen; Durham, Amy C.; Shifrovich, Ilya; Higley, J. Dee // Psychopharmacology;Mar2005, Vol. 178 Issue 2/3, p339 

    Presents a study on the time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Objectives of the study; Study methods; Results.

  • Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Yu, Y.W.-Y.; Tsai, S.-J.; Chen, T.-J.; Lin, C.-H.; Hong, C.-J. // Molecular Psychiatry;2002, Vol. 7 Issue 10, p1115 

    Tests the hypothesis that the 5-serotonin transporter gene-linked polymorphic region polymorphism is associated with serotonin reuptake inhibitors (SSRI) antidepressant response. Evaluation of the total and cluster depressive symptoms for 121 Chinese patients diagnosed with major depression;...

  • Accumulation of an Antidepressant in Vesiculogenic Membranes of Yeast Cells Triggers Autophagy. Jingqiu Chen; Korostyshevsky, Daniel; Sean Lee; Perlstein, Ethan O. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Many antidepressants are cationic amphipaths, which spontaneously accumulate in natural or reconstituted membranes in the absence of their specific protein targets. However, the clinical relevance of cellular membrane accumulation by antidepressants in the human brain is unknown and hotly...

  • Accumulation of an Antidepressant in Vesiculogenic Membranes of Yeast Cells Triggers Autophagy. Jingqiu Chen; Korostyshevsky, Daniel; Sean Lee; Perlstein, Ethan O. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Many antidepressants are cationic amphipaths, which spontaneously accumulate in natural or reconstituted membranes in the absence of their specific protein targets. However, the clinical relevance of cellular membrane accumulation by antidepressants in the human brain is unknown and hotly...

  • DEPRESSION IMPROVEMENT AND FIVE SECONDARY OUTCOMES. Stoltzfoos, Lonnie // Primary Psychiatry;Apr2008, Vol. 15 Issue 4, p17 

    The article reports on a study that traced the improvement of secondary deficits associated with depression and then compared those results with the results of the actual depressive symptoms. It states that recipients of selective serotonin reuptake inhibitor (SSRI) treatment for depression may...

  • Antidepressant-induced mania in obsessive compulsive disorder. Philip, Johann; Janaki, R. // Indian Journal of Psychiatry;Apr-Jun2012, Vol. 54 Issue 2, p194 

    Serotonin-reuptake inhibitors have come forth to become the mainstay of treatment in obsessive compulsive disorder (OCD), predominantly as a result of evidence from clinical psychopharmacological response studies. Comorbid psychiatric disorders frequent OCD patients, most often depression....

  • DRUG PROBLEM. Weir, Kirsten // Current Science;11/21/2003, Vol. 89 Issue 7, p8 

    Depression is a psychiatric disorder marked by an inability to concentrate, loss of appetite, insomnia, and feelings of extreme sadness, guilt, and hopelessness. Many drugs are prescribed to treat depression including selective serotonin reuptake inhibitors (SSRIs). Side effects of SSRIs range...

  • Coping, but only just.  // BMJ: British Medical Journal (International Edition);10/26/2002, Vol. 325 Issue 7370, p977 

    Presents the experiences of a general practitioner with the treatment of depression. Use of selective serotonin reuptake inhibitors; How the doctor kept treating patients despite his depression; Involvement of the National Health Service in England.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics